Status:
COMPLETED
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Cancer of Cervix
Cervical Cancer
Eligibility:
FEMALE
18-65 years
Phase:
PHASE3
Brief Summary
Radiation therapy still remains mainstay of treatment for patients with carcinoma cervix in advanced stages. Conventional treatment with radiation therapy includes a combination of external beam radia...
Detailed Description
Carcinoma cervix is the most common malignancy in Indian women and constitutes approximately 27% of all cancers as recorded in the annual report of Hospital based cancer registry 1991. Carcinoma of ce...
Eligibility Criteria
Inclusion
- Histologically proven squamous carcinoma of cervix
- Performance index WHO grade 0 or 1
- Patients below 65 years of age
- Normal ECG and CVS
- Normal hematological parameters
- Normal renal and liver function tests
Exclusion
- Concomitant disease which may adversely affect the outcome
- Poor nutritional status
- Medical or psychological condition precluding treatment
- Previous treatment
Key Trial Info
Start Date :
May 1 1996
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00193830
Start Date
May 1 1996
End Date
January 1 2007
Last Update
May 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400 012